<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about LPDX</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Fri, 24 May 2013 22:12:34 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=LPDX" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/distressed-investor-wilbur-ross-buys-2-stocks-cm246759">
      <guid isPermaLink="false">246759</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4E6Sf3ZM8ik/distressed-investor-wilbur-ross-buys-2-stocks-cm246759</link>
      <category>Investing</category>
      <title>Distressed Investor Wilbur Ross Buys 2 Stocks</title>
      <description>Billionaire  Wilbur Ross  primarily invests in failed companies and leveraged buyouts. His business deals typically involve industries such as coal, steel, telecommunications, foreign&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/4E6Sf3ZM8ik" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 17 May 2013 00:26:53 Z</pubDate>
      <a10:updated>2013-05-16T21:27:22Z</a10:updated>
      <author>Holly LaFon</author>
      <nasdaq:tickers>LPDX</nasdaq:tickers>
      <nasdaq:tickers>SEM</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/distressed-investor-wilbur-ross-buys-2-stocks-cm246759</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/ipo-madness-2013-round-two-recap-and-final-four-preview-cm234756">
      <guid isPermaLink="false">234756</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-OuHsdAQNG8/ipo-madness-2013-round-two-recap-and-final-four-preview-cm234756</link>
      <category>News Headlines</category>
      <category>IPOs</category>
      <title>IPO Madness 2013: Round Two Recap and Final Four Preview</title>
      <description>With many of the IPOs producing slam-dunk returns in 2013, Renaissance Capital would like to present the inaugural IPO Madness. To qualify, a company had to go public in 2013 and complete&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/-OuHsdAQNG8" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 09 Apr 2013 00:41:50 Z</pubDate>
      <a10:updated>2013-04-08T22:06:45Z</a10:updated>
      <author>Renaissance Capital</author>
      <nasdaq:tickers>APAM</nasdaq:tickers>
      <nasdaq:tickers>BCC</nasdaq:tickers>
      <nasdaq:tickers>LPDX</nasdaq:tickers>
      <nasdaq:tickers>TPH</nasdaq:tickers>
      <nasdaq:tickers>WSTC</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/ipo-madness-2013-round-two-recap-and-final-four-preview-cm234756</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/weekly-recap-bright-horizons-shines-six-us-ipos-set-terms-cm211295">
      <guid isPermaLink="false">211295</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z4KRKKMWy74/weekly-recap-bright-horizons-shines-six-us-ipos-set-terms-cm211295</link>
      <category>News Headlines</category>
      <category>IPOs</category>
      <title>Weekly recap: Bright Horizons shines, six US IPOs set terms</title>
      <description>Child care provider Bright Horizons' (  BFAM  ) 29% first-day gain topped another positive week in the US IPO market. Both Bright Horizons and diagnostics company LipoScience (  LPDX  ) priced&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Z4KRKKMWy74" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 28 Jan 2013 18:14:17 Z</pubDate>
      <a10:updated>2013-01-28T15:18:57Z</a10:updated>
      <author>Renaissance Capital</author>
      <nasdaq:tickers>BFAM</nasdaq:tickers>
      <nasdaq:tickers>LPDX</nasdaq:tickers>
      <nasdaq:tickers>NCLH</nasdaq:tickers>
      <nasdaq:tickers>PZE</nasdaq:tickers>
      <nasdaq:tickers>QGOG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/weekly-recap-bright-horizons-shines-six-us-ipos-set-terms-cm211295</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/liposcience-prices-ipo-at-9-36-below-original-midpoint-cm210758">
      <guid isPermaLink="false">210758</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EvVi7fOUM8Q/liposcience-prices-ipo-at-9-36-below-original-midpoint-cm210758</link>
      <category>News Headlines</category>
      <category>IPOs</category>
      <title>LipoScience prices IPO at $9, 36% below original midpoint</title>
      <description>LipoScience, which provides a diagnostic test to assess cardiovascular disease risk, raised $45 million on Thursday by offering 5 million shares at $9, 36% below the midpoint of the original&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/EvVi7fOUM8Q" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 25 Jan 2013 17:47:19 Z</pubDate>
      <a10:updated>2013-01-25T15:16:58Z</a10:updated>
      <author>Renaissance Capital</author>
      <nasdaq:tickers>LPDX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/liposcience-prices-ipo-at-9-36-below-original-midpoint-cm210758</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/liposcience-lowers-price-range-32-to-910-cm210627">
      <guid isPermaLink="false">210627</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ISRzKKo6iy4/liposcience-lowers-price-range-32-to-910-cm210627</link>
      <category>News Headlines</category>
      <category>IPOs</category>
      <title>LipoScience lowers price range 32% to $9-$10</title>
      <description>LipoScience, which provides an LDL diagnostic test to assess cardiovascular disease risk, lowered the proposed price range for its upcoming IPO on Thursday. The Raleigh, NC-based company now&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/ISRzKKo6iy4" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 25 Jan 2013 03:41:59 Z</pubDate>
      <a10:updated>2013-01-25T01:15:10Z</a10:updated>
      <author>Renaissance Capital</author>
      <nasdaq:tickers>LPDX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/liposcience-lowers-price-range-32-to-910-cm210627</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/2-us-ipos-planned-for-the-week-of-jan-21-cm209066">
      <guid isPermaLink="false">209066</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bqr2YhVTCkE/2-us-ipos-planned-for-the-week-of-jan-21-cm209066</link>
      <category>News Headlines</category>
      <category>IPOs</category>
      <title>2 US IPOs planned for the week of Jan 21</title>
      <description>The following  IPOs are expected to price this week  :   Bright Horizons Family Solutions  (  BFAM  ), which is leading provider of work site child care and early education centers, plans to&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/bqr2YhVTCkE" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 21 Jan 2013 17:00:03 Z</pubDate>
      <a10:updated>2013-01-21T14:14:21Z</a10:updated>
      <author>Renaissance Capital</author>
      <nasdaq:tickers>BFAM</nasdaq:tickers>
      <nasdaq:tickers>LPDX</nasdaq:tickers>
      <nasdaq:tickers>NCLH</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/2-us-ipos-planned-for-the-week-of-jan-21-cm209066</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/diagnostic-company-liposcience-sets-terms-for-70-million-ipo-cm206447">
      <guid isPermaLink="false">206447</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9MZpp7-F6cc/diagnostic-company-liposcience-sets-terms-for-70-million-ipo-cm206447</link>
      <category>News Headlines</category>
      <category>IPOs</category>
      <title>Diagnostic company LipoScience sets terms for $70 million IPO</title>
      <description>LipoScience, which provides an LDL diagnostic test to assess cardiovascular disease risk, announced terms for its IPO on Thursday. The Raleigh, NC-based company plans to raise $70 million by&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/9MZpp7-F6cc" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 11 Jan 2013 02:19:26 Z</pubDate>
      <a10:updated>2013-01-11T00:13:35Z</a10:updated>
      <author>Renaissance Capital</author>
      <nasdaq:tickers>LPDX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/diagnostic-company-liposcience-sets-terms-for-70-million-ipo-cm206447</feedburner:origLink></item>
  </channel>
</rss>
